Five-year Outcomes of Sleeve Gastrectomy: A Prospective Multicenter study

Abstract

Background

Sleeve gastrectomy (SG) is the most frequently performed bariatric procedure in the world. Our purpose was to evaluate the percentage of excess weight loss (%EWL), resolution of obesity-related comorbidities after SG, and identify predictive factors of weight loss failure.

Methods

A prospective cohort study of adults who underwent SG during 2014 in 7 Belgian-French centers. Their demographic, preoperative, and postoperative data were prospectively collected and analyzed statistically.

Results

Overall, 529 patients underwent SG, with a mean preoperative weight and body mass index (BMI) of 118.9 ± 19.9 kg and 42.9 ± 5.5 kg/m², respectively. Body mass index significantly decreased to 32.2 kg/m² at 5 years (P < .001). The mean %EWL was 63.6% at 5 years. A significant reduction in dyslipidemia (28.0%-18.2%), obstructive sleep apnea (OSAS) (34.6%-25.1%), and arterial hypertension (HTN) (30.4%-21.5%) was observed after 5 years, but not for diabetes and gastroesophageal reflux disease (GERD). At multivariate analysis, age >50 years old, BMI >50 kg/m², and previous laparoscopic adjustable gastric banding (LAGB) remained independent predictors of weight loss failure.

Conclusions

Five years after SG, weight loss was satisfactory; the reduction of comorbidities was significant for dyslipidemia, OSAS, and HTN, but not diabetes and GERD. Age >50 years old, BMI >50 kg/m², and previous LAGB were independent predictors of weight loss failure.

Keywords

sleeve gastrectomy obesity-related comorbidities postoperative outcome excess weight loss weight loss failure

Get full access to this article

View all access options for this article.

References

Lagace

Marceau

, et al. Biliopancreatic diversion with a new type of gastrectomy: Some previous conclusions revisited. Obes Surg. 1995;5(4):411-418.

Regan

Inabnet

Gagner

Pomp

. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg. 2003;13(6):861-944.

Elsenreich

Langer

Prager

. Weight loss and resolution of comorbidities after sleeve gastrectomy: A review of long-term results. Scand J Surg. 2019;108(1):3-9.

Welbourn

Hollyman

Kinsman

, et al. Bariatric surgery worldwide: Baseline demographic description and one-year outcomes from the fourth IFSO global registry report 2018. Obes Surg. 2019;29(3):782-795.

Karamanakos

Vagenas

Kalfarentzos

Alexandrides

. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: A prospective, double blind study. Ann Surg. 2008;247(3):401-407.

Melissas

Daskalakis

Koukouraki

, et al. Sleeve gastrectomy a "food limiting" operation. Obes Surg. 2008;18(10):1251-1256.

Langer

Reza Hoda

Bohdjalian

, et al. Sleeve gastrectomy and gastric banding: Effects on plasma ghrelin levels. Obes Surg 2005;15(7):1024-1029.

Diamantis

Apostolou

Alexandrou

Griniatsos

Felekouras

Tsigris

. Review of long-term weight loss results after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2014;10(1):177-183.

Pedrosa

Drager

de Paula

LKG

Amaro

ACS

Bortolotto

Lorenzi-Filho

. Effects of OSA treatment on BP in patients with resistant hypertension: A randomized trial. Chest. 2013;144(5):1487-1494.

10.

Samson

Milligan

Lewine

, et al. Effect of sleeve gastrectomy on hypertension. J Am Soc Hypertens. 2018;12(11):e19-e25.

11.

Auclair

Biertho

Marceau

, et al. Bariatric surgery-induced resolution of hypertension and obstructive sleep apnea: Impact of modulation of body fat, ectopic fat, autonomic nervous activity, inflammatory and adipokine profiles. Obes Surg. 2017;27(12):3156-3164.

12.

Oparil

Zaman

Calhoun

. Pathogenesis of hypertension. Ann Intern Med. 2003;139(9):761-776.

13.

Cowan

Livingston

. Obstructive sleep apnoea syndrome and weight loss: review. Sleep Disord. 2012;2012:163296.

14.

Gill

Birch

Shi

Sharma

Karmali

. Sleeve gastrectomy and type 2 diabetes mellitus: A systematic review. Surg Obes Relat Dis. 2010;6(6):707-713.

15.

Park

Nam

Choi

, et al. Comparative efficacy of bariatric surgery in the treatment of morbid obesity and diabetes mellitus: A systematic review and network meta-analysis. Obes Surg. 2019;29(7):2180-2190.

16.

Flølo

Andersen

Kolotkin

, et al. Five-year outcomes after vertical sleeve gastrectomy for severe obesity: A prospective cohort study. Obes Surg. 2017;27(8):1944-1951.

17.

Lortat-Jacob

Robert

. Les malpositions cardiotubérositaires. Arch Fr Mal Appareil Dig. 1953;42:750-774.

18.

Yehoshua

Eidelman

Stein

, et al. Laparoscopic sleeve gastrectomy—volume and pressure assessment. Obes Surg. 2008;18(9):1083-1088.

19.

Obeidat

Shanti

. Early weight loss as a predictor of 2-year weight loss and resolution of comorbidities after sleeve gastrectomy. Obes Surg. 2016;26(6):1173-1177.

20.

Ortega

Morínigo

Flores

, et al. Predictive factors of excess body weight loss 1 year after laparoscopic bariatric surgery. Surg Endosc. 2012;26(6):1744-1750.

21.

Pujol Rafols

Al Abbas

Devriendt

, et al. Roux-en-Y gastric bypass, sleeve gastrectomy, or one anastomosis gastric bypass as rescue therapy after failed adjustable gastric banding: a multicenter comparative study. Surg Obes Relat Dis. 2018;14(11):1659-1666.

22.

Yuval

Mintz

Cohen

Rivkind

Elazary

. The effects of bougie caliber on leaks and excess weight loss following laparoscopic sleeve gastrectomy. Is there an ideal bougie size?. Obes Surg. 2013;23(10):1685-1691.

23.

Garay

Balague

Rodriguez-Otero

, et al. Influence of antrum size on gastric emptying and weight-loss outcomes after laparoscopic sleeve gastrectomy (preliminary analysis of a randomized trial). Surg Endosc. 2018;32(6):2739-2745.

24.

ElGeidie

ElHemaly

Hamdy

El Sorogy

AbdelGawad

GadElHak

. The effect of residual gastric antrum size on the outcome of laparoscopic sleeve gastrectomy: a prospective randomized trial. Surg Obes Relat Dis. 2015;11(5):997-1003.